Why drugs fail--a study on side effects in new chemical entities.

Daniela Brigitte Schuster; C Laggner; T Langer

Why drugs fail--a study on side effects in new chemical entities.

Daniela Brigitte Schuster, C Laggner, T Langer

Research output: Contribution to journal › Review article › peer-review

269 Citations (Web of Science)

Original language	English
Pages (from-to)	3545-3559
Journal	CURRENT PHARMACEUTICAL DESIGN
Volume	11
Issue number	27
Publication status	Published - 2005

Keywords

CHRONIC HEART-FAILURE
FIALURIDINE
BRONCHOSPASM
RAPACURONIUM
AMINEPTINE
INHIBITORS
INNOVATION
INJURY
ANALOG

Cite this

Schuster, D. B., Laggner, C., & Langer, T. (2005). Why drugs fail--a study on side effects in new chemical entities. CURRENT PHARMACEUTICAL DESIGN , 11(27), 3545-3559.

Schuster, Daniela Brigitte ; Laggner, C ; Langer, T. / Why drugs fail--a study on side effects in new chemical entities. In: CURRENT PHARMACEUTICAL DESIGN 2005 ; Vol. 11, No. 27. pp. 3545-3559.

@article{0721f565db964ebfa21e4f18a2db179c,

title = "Why drugs fail--a study on side effects in new chemical entities.",

keywords = "CHRONIC HEART-FAILURE, FIALURIDINE, BRONCHOSPASM, RAPACURONIUM, AMINEPTINE, INHIBITORS, INNOVATION, INJURY, ANALOG",

author = "Schuster, {Daniela Brigitte} and C Laggner and T Langer",

year = "2005",

language = "English",

volume = "11",

pages = "3545--3559",

journal = "CURRENT PHARMACEUTICAL DESIGN ",

issn = "1381-6128",

number = "27",

}

Schuster, DB, Laggner, C & Langer, T 2005, 'Why drugs fail--a study on side effects in new chemical entities.', CURRENT PHARMACEUTICAL DESIGN , vol. 11, no. 27, pp. 3545-3559.

Why drugs fail--a study on side effects in new chemical entities. / Schuster, Daniela Brigitte; Laggner, C; Langer, T.
In: CURRENT PHARMACEUTICAL DESIGN , Vol. 11, No. 27, 2005, p. 3545-3559.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - Why drugs fail--a study on side effects in new chemical entities.

AU - Schuster, Daniela Brigitte

AU - Laggner, C

AU - Langer, T

PY - 2005

Y1 - 2005

KW - CHRONIC HEART-FAILURE

KW - FIALURIDINE

KW - BRONCHOSPASM

KW - RAPACURONIUM

KW - AMINEPTINE

KW - INHIBITORS

KW - INNOVATION

KW - INJURY

KW - ANALOG

M3 - Review article

C2 - 16248807

SN - 1381-6128

VL - 11

SP - 3545

EP - 3559

JO - CURRENT PHARMACEUTICAL DESIGN

JF - CURRENT PHARMACEUTICAL DESIGN

IS - 27

ER -

Schuster DB, Laggner C, Langer T. Why drugs fail--a study on side effects in new chemical entities. CURRENT PHARMACEUTICAL DESIGN . 2005;11(27):3545-3559.